A carregar...
Current perspectives on echinocandin class drugs
It has been nearly a decade since caspofungin was approved for clinical use as the first echinocandin class antifungal agent, followed by micafungin and anidulafungin. The echinocandin drugs target the fungal cell wall by inhibiting the synthesis of α-1,3-d-glucan, a critical cell wall component of...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913534/ https://ncbi.nlm.nih.gov/pubmed/21526945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb.11.19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|